| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,488,000 | 0.02% | ||
| 102 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,375,000 | 0.02% | PRN | |
| 103 | OHR PHARMACEUTICAL INC | 370,370 | 2,274,000 | 0.02% | ||
| 104 | STEMLINE THERAPEUTICS INC | 333,497 | 2,104,000 | 0.02% | ||
| 105 | MAST THERAPEUTICS INC COM | 4,797,442 | 2,016,000 | 0.02% | ||
| 106 | IRONWOOD PHARMACEUTICALS INC | 169,163 | 1,961,000 | 0.02% | ||
| 107 | MEDIWOUND ORD | 225,000 | 1,922,000 | 0.02% | ||
| 108 | ASSEMBLY BIOSCIENCES INC | 250,000 | 1,878,000 | 0.02% | ||
| 109 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 1,812,000 | 0.02% | ||
| 110 | AURINIA PHARMACEUTICALS INC | 711,499 | 1,789,000 | 0.01% | ||
| 111 | CYTRX CORP | 659,995 | 1,749,000 | 0.01% | ||
| 112 | CELLECTIS S A | 50,000 | 1,552,000 | 0.01% | ||
| 113 | Marinus Pharmaceuticals Inc | 200,000 | 1,528,000 | 0.01% | ||
| 114 | ACCELERON PHARMA INC | 28,765 | 1,403,000 | 0.01% | ||
| 115 | TENAX THERAPEUTICS INC | 420,000 | 1,378,000 | 0.01% | ||
| 116 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,361,000 | 0.01% | ||
| 117 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 1,206,000 | 0.01% | ||
| 118 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 1,068,000 | 0.01% | ||
| 119 | CHIMERIX INC | 115,216 | 1,031,000 | 0.01% | ||
| 120 | BIODELIVERY SCIENCES INTL IN | 210,021 | 1,006,000 | 0.01% | ||
| 121 | Aldeyra Therapeutics Inc | 142,000 | 963,000 | 0.01% | ||
| 122 | ARBUTUS BIOPHARMA CORP | 180,582 | 804,000 | 0.01% | ||
| 123 | FIVE PRIME THERAPEUTICS INC | 19,247 | 799,000 | 0.01% | ||
| 124 | DISCOVERY LABORATORIES INC N | 3,569,643 | 764,000 | 0.01% | ||
| 125 | RITTER PHARMACEUTICALS INC | 400,000 | 680,000 | 0.01% | ||
| 126 | ACHAOGEN INC COM | 100,000 | 574,000 | 0.00% | ||
| 127 | UNIQURE NV | 30,000 | 496,000 | 0.00% | ||
| 128 | Foundation Medicine | 20,892 | 440,000 | 0.00% | ||
| 129 | CHEMOCENTRYX INC | 49,064 | 397,000 | 0.00% | ||
| 130 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 371,000 | 0.00% | ||
| 131 | APTOSE BIOSCIENCES INC | 33,397 | 84,000 | 0.00% | ||
| 132 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 52,000 | 0.00% | ||
| 133 | BIOTIME INC | 20,084 | 24,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-082790, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
